Taken together, this study indicated that NTF-SCs-CM and NTF-SCs could reduce the GSK-3β level in AD mice which is in contrast to the up-regulation of PI3K, Akt, MAPK, ERK, Wnt3a, and β-catenin. Here, AKT1 is linked to Alzheimer disease.